You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
消息稱歸創通橋-B(2190.HK)IPO定價為42.70港元/股
格隆匯 06-28 11:20
格隆匯6月28日丨據市場消息,內地神經和外周血管介入醫療器械生產商歸創通橋-B(2190.HK)IPO定價為42.70港元/股,為招股價範圍39.8至42.7港元的上限。公司發行6000萬股,集資最多25.62億港元。一手500股,入場費21565.14港元。股份將於7月5日掛牌。摩根士丹利和中信證券為其聯席保薦人。歸創通橋是中國神經和外周血管介入醫療器械市場的領導者,目前公司的治療領域包括急性缺血性腦卒中(AIS)、顱內動脈瘤、頸動脈狹窄、外周動脈和靜脈疾病及透析相關疾病。公司此次IPO獲高瓴、富達國際及清池資本等基石投資者合共認購1.45億美元。歸創通橋招股反應熱烈,據悉,吸引了43.9萬人認購,公開發售超購1190倍,凍資3080億港元,為近期新股中最熱。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account